Elevance Health Stock Drops 7.7%

Analysts Debate Whether It's Time to Sell the Health Insurance Giant

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

Shares of Elevance Health (NYSE:ELV) fell 7.7% on Monday, trading as low as $298.70. The company's stock has seen a decline in trading volume, down 33% from its average daily volume. Analysts are divided on whether investors should sell the health insurance giant, with some maintaining a 'buy' rating while others have lowered their price targets.

Why it matters

Elevance Health is one of the largest health insurance providers in the United States, serving millions of customers through its various plans and programs. The company's stock performance is closely watched by investors and analysts as an indicator of the overall health of the insurance industry and the broader healthcare sector.

The details

The drop in Elevance Health's stock price comes after the company reported its latest financial results, which included a decline in revenue and earnings compared to the previous year. Analysts have cited a number of factors that may be contributing to the stock's decline, including increased competition in the insurance market, regulatory changes, and concerns about the company's ability to maintain its profitability.

  • Elevance Health's stock price fell 7.7% on Monday, March 2, 2026.

The players

Elevance Health, Inc.

A large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc. to Elevance Health in 2022.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

The drop in Elevance Health's stock price highlights the ongoing challenges facing the health insurance industry, as companies navigate a rapidly changing regulatory environment, increased competition, and shifting consumer preferences. Investors will be closely watching the company's next moves as it seeks to maintain its market share and profitability in the face of these headwinds.